Nocturnal activity of a "diurnal" species, the northern chamois, in a predator-free Alpine area.

The reduction of predation risk is widely considered a major factor affecting the nocturnal activity of mammals. Furthermore, on precipitous mountain terrain, moving in very poor light conditions should be avoided by animals with no special eyesight adaptation to darkness. The Northern chamois Rupicapra rupicapra has been for long considered as a diurnal species, with occasional nocturnal movements. For the first time, we have quantified the nocturnal activity of 21 radiotagged female chamois from the Italian Eastern Alps (Paneveggio-Pale di San Martino Natural Park), continuously monitored for two years from sunset to sunrise, with 24h tracking sessions carried out for six months. Large predators were not present in the study site. Despite their mainly diurnal activity pattern, peaks of nocturnal movements were detected throughout the year. The least proportion of active night fixes occurred in January and in July, while the most were in April and in October. The greater nocturnal activity in the warm months compared to cold periods, was probably due to frozen snow cover reducing nocturnal movements. Movements were mainly concentrated in bright moonlight nights, possibly because of the absence of large predators, but more likely because of increased visibility. Changes in activity levels throughout the year may also reflect changes in energy requirements of Northern chamois.

Effects of acepromazine on the stress response in Southern chamois (Rupicapra pyrenaica) captured by means of drive-nets.

This study was conducted to assess the stress response of Southern chamois (Rupicapra pyrenaica) to capture and physical restraint and the effects of acepromazine (a short-acting neuroleptic) on this response. Forty free-ranging Southern chamois were captured, injected intramuscularly with acepromazine (19 animals, randomly selected) or saline (the other 21 animals), and physically restrained for 3 h. Heart rate and body temperature were monitored with telemetric devices, and blood samples were obtained at capture and every hour thereafter to determine hematologic and serum biochemical parameters. The lower heart-rate variability, temperature, erythrocyte count, hemoglobin concentration, packed cell volume (PCV), and serum creatine kinase activity in the animals treated with acepromazine indicated that this agent reduced the adverse effects of stress. According to the differences in heart rate, erythrocyte count, hemoglobin concentration, PCV, lymphocyte count, and serum concentrations of glucose, creatinine, chloride, and potassium, alpha-adrenergic stimulation by catecholamines seemed to be stronger in females, whereas the adrenal-cortex reaction seemed to be stronger in males. The differences in erythrocyte parameters, temperature, serum creatine kinase activity, and serum concentrations of potassium and chloride indicated that acepromazine's beneficial effects were greater in females.

Transport stress in Southern chamois (Rupicapra pyrenaica) and its modulation by acepromazine.

Chamois have been translocated for more than 100 years but their stress response to transport remains to be elucidated. In this study, 21 free-ranging Southern chamois were captured, physically restrained and then transported. The animals were randomly injected intramuscularly with acepromazine (nine adult males, one adult female and one yearling male) or saline (five adult males, two adult females and three yearling males). Heart rate and body temperature were monitored with telemetric devices, and blood samples were obtained at capture, immediately before and immediately after transport to determine haematological and serum biochemical parameters. Heart rate and blood parameters (erythrocytes, haemoglobin, packed cell volume, leukocytes, monocytes, band neutrophils, lactate, muscular enzymes and creatinine) indicated that transport was more stressful than previous physical restraint. Acepromazine reduced the adverse consequences of transport stress, as demonstrated by heart rate, body temperature, cortisol, creatinine, muscular enzymes, urea, sodium and potassium.